secwatch.observer — SEC 8-K summary
======================================

Issuer:     VivoSim Labs, INC. (VIVS)
CIK:        0001497253
Form:       8-K
Filed at:   2024-08-09T23:59:59+00:00
Accession:  0000950170-24-094736
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Organovo grants Chairman Murphy options on ~1M shares at $0.5368, vesting over 3 years
--------------------------------------------------------------------------------

- Time-based option for 574,923 shares vests 1/3 annually over 3 years subject to continued service.
- Performance-based option for 431,193 shares vests upon achieving revenue, market cap, stock price, and strategic goals.
- Additional 'True-Up Options' may be granted if equity financing closes by March 31, 2025, below specified dilution thresholds.
- Options granted under 2022 Equity Incentive Plan, approved by Compensation Committee on August 4, 2024.
- Exercise price set at $0.5368 per share; grant date is August 5, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1497253/000095017024094736/0000950170-24-094736-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1497253/000095017024094736/onvo-20240805.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-094736

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer